125
Views
4
CrossRef citations to date
0
Altmetric
Clinical Focus: Diabetes and Concomitant Disorders

Influence of Baseline Glycemia on Outcomes With Insulin Glargine Use in Patients Uncontrolled on Oral Agents

, MD, , MD, , ME & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tri Juli Edi Tarigan, Adisti Dwijayanti, Susie Setyowati & Melva Louisa. (2021) Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes. Diabetes, Metabolic Syndrome and Obesity 14, pages 107-116.
Read now

Articles from other publishers (3)

Chaicharn Deerochanawong, Shailendra Bajpai, I. Made Pande Dwipayana, Zanariah Hussein, Maria Aileen Mabunay, Reynaldo Rosales, Shih-Tzer Tsai & Man Wo Tsang. (2017) Optimizing Glycemic Control Through Titration of Insulin Glargine 100 U/mL: A Review of Current and Future Approaches with a Focus on Asian Populations. Diabetes Therapy 8:6, pages 1197-1214.
Crossref
Eliziane Brandão Leite, Hermelinda Cordeiro Pedrosa & Luiz Augusto Casulari. (2015) Results of glycated hemoglobin during treatment with insulin analogues dispensed in the public health system of Federal District in Brazil. Diabetology & Metabolic Syndrome 7:1.
Crossref
Mohammad Ishraq Zafar, Cuining Hu, Danfeng Liu, Raja Adeel Shafqat & Feng Gao. (2014) Insulin Detemir Causes Lesser Weight Gain in Comparison to Insulin Glargine: Role on Hypothalamic NPY and Galanin. Journal of Diabetes Research 2014, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.